Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor

Life Health > Health Insurance > Health Insurance

Anthem proposes to buy rival insurer Cigna for $47 billion

X
Your article was successfully shared with the contacts you provided.

(Bloomberg) — Anthem Inc. (NYSE:ANTM) made a non-binding proposal to buy smaller health insurer Cigna Corp. (NYSE:CI) for about $47 billion in what would be the industry’s biggest takeover ever.

The proposed offer is for $184 a share, about 31 percent of which would be paid in Anthem shares and the rest in cash. That’s a 29 percent premium to Cigna’s average closing price in the past 20 trading sessions. Anthem said the total transaction value is $53.8 billion, including net debt.

See also: Insurers from Cigna to Aetna jump as merger mania catches on

The merged entity would be about 24 percent owned by Cigna shareholders and would serve about 53 million members.

Health insurance companies are on the verge of a consolidation wave much like the pharmaceutical industry has been experiencing. Companies such as Anthem are searching for ways to cut costs and keep profits expanding amid a surge in enrollment from the Patient Protection and Affordable Care Act (PPACA).

Anthem said Saturday that combining with Cigna would boost adjusted earnings by more than 10 percent in the first year. Together, they’ll generate more than $115 billion in annual revenue.

Anthem, valued at $43 billion on Friday, was considering a takeover of Cigna or Humana Inc. (NYSE:HUM), a person familiar with the matter said this month. Chris Rigg, an analyst for Susquehanna Financial Group, said at the time that should Anthem choose to target Cigna, then Aetna Inc. (NYSE:HUM) may pursue Humana.


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.